Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Germany

Germany Articles

Industry

The European Commission (EC) has made a formal request that Germany and Portugal review their laws on the ownership of pharmacies. The requests - which take the form of Reasoned Opinions... 2008-09-26


Companies

Israel's Teva Pharmaceutical Industries has moved to end speculation that it is eying up an acquisition of Germany's Stada Arzneimittel. Teva's North American CEO William Marth stated... 2008-09-22


Industry

Germany's largest health insurance fund Allgemeine Ortskrankenkasse (AOK) has initiated the first Europe-wide tenders for contracts to supply generic drugs, in an effort to spark... 2008-08-12


Industry

Bayer Healthcare's oral anticoagulant, Xarelto (rivaroxaban), has been recommended for EU marketing authorisation by the European Medicine Agency (EMEA)'s Committee for Products for... 2008-07-28


Industry

Strong growth in Central and Eastern Europe (CEE) for Sandoz, Novartis' generics division, has made a significant contribution to the generics company's H108 results. In US dollar... 2008-07-24


Industry

India is one the leading emerging markets for pharmaceutical companies. Sales of medicines are experiencing double digit growth each year, low labour costs makes it a premier manufacturing... 2008-07-24


Industry

Germany's drug discount contracts - which enforce pharmacists to dispense drugs for which health insurers have arranged price reductions with pharmaceutical companies - appear to... 2008-07-21


Companies

Germany-based global healthcare company Fresenius SE has agreed to buy US generic intravenous (IV) drug specialist APP Pharmaceuticals in a deal worth an initial US$3.7bn.

2008-07-08

Companies

Not wanting to be left behind in the current spate of biotech acquisitions, UK based Shire has struck a deal to acquire German firm Jerini for EUR349mn (US$548mn). In what Jerini... 2008-07-04


Industry

BMI believes there is significant global growth potential for third party active pharmaceutical ingredient (API) inspection firms over the next few years. This is in light of the... 2008-06-12

1 to 10 of 80 results
<< | < | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | > | >>
Insight